Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Breast Neoplasms | 108 | 2023 | 2887 | 8.410 |
Why?
|
Mammography | 70 | 2019 | 461 | 5.570 |
Why?
|
Artificial Intelligence | 21 | 2023 | 298 | 5.210 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 56 | 2019 | 466 | 4.580 |
Why?
|
Diagnosis, Computer-Assisted | 48 | 2020 | 332 | 4.550 |
Why?
|
Ultrasonography, Mammary | 20 | 2016 | 82 | 3.570 |
Why?
|
Radiographic Image Enhancement | 68 | 2019 | 462 | 3.240 |
Why?
|
Diagnostic Imaging | 18 | 2022 | 469 | 3.220 |
Why?
|
Image Processing, Computer-Assisted | 47 | 2021 | 1204 | 3.150 |
Why?
|
Breast | 16 | 2021 | 286 | 3.070 |
Why?
|
Image Interpretation, Computer-Assisted | 30 | 2021 | 663 | 3.000 |
Why?
|
ROC Curve | 67 | 2023 | 752 | 2.790 |
Why?
|
Magnetic Resonance Imaging | 34 | 2023 | 3352 | 2.760 |
Why?
|
Radiology | 12 | 2022 | 194 | 2.190 |
Why?
|
Machine Learning | 10 | 2023 | 232 | 2.170 |
Why?
|
Algorithms | 38 | 2023 | 1830 | 1.770 |
Why?
|
Hypoxia-Ischemia, Brain | 2 | 2022 | 52 | 1.610 |
Why?
|
Image Enhancement | 15 | 2018 | 563 | 1.440 |
Why?
|
Brain Injuries | 2 | 2022 | 161 | 1.420 |
Why?
|
Humans | 229 | 2023 | 86601 | 1.340 |
Why?
|
Female | 136 | 2023 | 44507 | 1.230 |
Why?
|
Lupus Nephritis | 5 | 2022 | 78 | 1.140 |
Why?
|
Radiography, Thoracic | 26 | 2021 | 320 | 1.130 |
Why?
|
Radiography | 15 | 2018 | 813 | 1.080 |
Why?
|
Carcinoma, Ductal, Breast | 3 | 2015 | 156 | 1.040 |
Why?
|
Pattern Recognition, Automated | 16 | 2013 | 217 | 1.010 |
Why?
|
Retrospective Studies | 32 | 2023 | 8475 | 0.960 |
Why?
|
Tomography, X-Ray Computed | 23 | 2023 | 2600 | 0.930 |
Why?
|
Lymph Nodes | 3 | 2015 | 530 | 0.890 |
Why?
|
Emphysema | 1 | 2023 | 22 | 0.880 |
Why?
|
Pulmonary Emphysema | 1 | 2023 | 30 | 0.880 |
Why?
|
Middle Aged | 49 | 2023 | 25017 | 0.850 |
Why?
|
Sensitivity and Specificity | 41 | 2018 | 1990 | 0.850 |
Why?
|
Magnets | 1 | 2021 | 14 | 0.810 |
Why?
|
Cells | 1 | 2021 | 32 | 0.800 |
Why?
|
Radiometry | 4 | 2023 | 53 | 0.790 |
Why?
|
Microscopy | 1 | 2021 | 87 | 0.780 |
Why?
|
Health Physics | 4 | 2018 | 18 | 0.770 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2018 | 1313 | 0.770 |
Why?
|
Out-of-Hospital Cardiac Arrest | 1 | 2021 | 67 | 0.760 |
Why?
|
Calcaneus | 4 | 2010 | 34 | 0.760 |
Why?
|
Organ Specificity | 1 | 2021 | 258 | 0.760 |
Why?
|
Breast Diseases | 14 | 2018 | 97 | 0.730 |
Why?
|
Aged | 41 | 2020 | 18402 | 0.720 |
Why?
|
Adult | 45 | 2021 | 25640 | 0.720 |
Why?
|
Physics | 2 | 2018 | 22 | 0.680 |
Why?
|
Heart Arrest | 1 | 2022 | 265 | 0.670 |
Why?
|
Risk Assessment | 7 | 2019 | 2261 | 0.660 |
Why?
|
Databases, Factual | 11 | 2018 | 812 | 0.650 |
Why?
|
Research Report | 1 | 2018 | 44 | 0.650 |
Why?
|
Medical Informatics | 1 | 2018 | 47 | 0.640 |
Why?
|
Aged, 80 and over | 25 | 2019 | 6501 | 0.620 |
Why?
|
Mammary Glands, Human | 2 | 2014 | 22 | 0.620 |
Why?
|
Societies, Scientific | 1 | 2018 | 44 | 0.620 |
Why?
|
Radiotherapy | 2 | 2020 | 328 | 0.620 |
Why?
|
Decision Support Techniques | 2 | 2020 | 160 | 0.610 |
Why?
|
Axilla | 2 | 2014 | 97 | 0.610 |
Why?
|
Reproducibility of Results | 29 | 2022 | 2705 | 0.590 |
Why?
|
Contrast Media | 15 | 2021 | 1077 | 0.590 |
Why?
|
Societies, Medical | 2 | 2018 | 572 | 0.570 |
Why?
|
Biomedical Research | 5 | 2012 | 375 | 0.560 |
Why?
|
False Positive Reactions | 23 | 2014 | 216 | 0.550 |
Why?
|
Lung | 14 | 2023 | 1170 | 0.550 |
Why?
|
Imaging, Three-Dimensional | 9 | 2014 | 579 | 0.550 |
Why?
|
Lymphatic Metastasis | 2 | 2014 | 481 | 0.540 |
Why?
|
Calcinosis | 16 | 2010 | 224 | 0.530 |
Why?
|
Carcinoma, Lobular | 1 | 2015 | 80 | 0.510 |
Why?
|
Genes, BRCA2 | 3 | 2014 | 160 | 0.500 |
Why?
|
Genes, BRCA1 | 4 | 2014 | 192 | 0.500 |
Why?
|
Genomics | 2 | 2019 | 720 | 0.500 |
Why?
|
Absorptiometry, Photon | 5 | 2007 | 99 | 0.480 |
Why?
|
Diagnosis, Differential | 16 | 2018 | 1565 | 0.460 |
Why?
|
Neoplasms | 6 | 2020 | 2897 | 0.460 |
Why?
|
Breast Density | 4 | 2019 | 31 | 0.440 |
Why?
|
Carcinoma | 2 | 2016 | 436 | 0.440 |
Why?
|
Area Under Curve | 14 | 2014 | 334 | 0.440 |
Why?
|
Artifacts | 5 | 2018 | 244 | 0.430 |
Why?
|
Solitary Pulmonary Nodule | 8 | 2002 | 138 | 0.430 |
Why?
|
Subtraction Technique | 9 | 2011 | 133 | 0.400 |
Why?
|
Radiography, Interventional | 5 | 2016 | 150 | 0.400 |
Why?
|
Early Detection of Cancer | 3 | 2022 | 392 | 0.400 |
Why?
|
Bone Density | 11 | 2010 | 209 | 0.390 |
Why?
|
User-Computer Interface | 3 | 2010 | 185 | 0.380 |
Why?
|
Catheterization | 4 | 2016 | 232 | 0.380 |
Why?
|
Phenotype | 8 | 2022 | 2377 | 0.380 |
Why?
|
Biopsy | 11 | 2021 | 1161 | 0.370 |
Why?
|
Movement | 3 | 2007 | 299 | 0.370 |
Why?
|
Academic Medical Centers | 1 | 2012 | 379 | 0.350 |
Why?
|
Observer Variation | 15 | 2013 | 602 | 0.340 |
Why?
|
Tumor Burden | 3 | 2019 | 288 | 0.330 |
Why?
|
Signal-To-Noise Ratio | 3 | 2018 | 96 | 0.320 |
Why?
|
Predictive Value of Tests | 7 | 2018 | 1673 | 0.300 |
Why?
|
Mutation | 6 | 2015 | 3967 | 0.270 |
Why?
|
Technology, Radiologic | 9 | 1996 | 103 | 0.270 |
Why?
|
Lung Neoplasms | 11 | 2016 | 2261 | 0.270 |
Why?
|
Pilot Projects | 8 | 2023 | 839 | 0.270 |
Why?
|
Data Collection | 2 | 2013 | 372 | 0.260 |
Why?
|
Catheters | 2 | 2016 | 74 | 0.260 |
Why?
|
Gastrostomy | 2 | 2016 | 69 | 0.260 |
Why?
|
Fetus | 2 | 2023 | 226 | 0.250 |
Why?
|
Biomarkers | 4 | 2022 | 1718 | 0.250 |
Why?
|
Precision Medicine | 2 | 2019 | 395 | 0.250 |
Why?
|
Hydronephrosis | 1 | 2023 | 31 | 0.240 |
Why?
|
Catheters, Indwelling | 2 | 2014 | 110 | 0.240 |
Why?
|
Software | 11 | 2023 | 654 | 0.230 |
Why?
|
Phantoms, Imaging | 7 | 2023 | 429 | 0.230 |
Why?
|
Technology Assessment, Biomedical | 3 | 2012 | 27 | 0.220 |
Why?
|
Computer Simulation | 7 | 2014 | 1078 | 0.220 |
Why?
|
Forecasting | 3 | 2020 | 304 | 0.210 |
Why?
|
Coma | 1 | 2021 | 44 | 0.210 |
Why?
|
Heart | 3 | 2010 | 539 | 0.200 |
Why?
|
Osteoporosis | 5 | 2010 | 121 | 0.200 |
Why?
|
NADP | 1 | 2021 | 45 | 0.200 |
Why?
|
Hormones | 1 | 2021 | 140 | 0.190 |
Why?
|
Data Mining | 2 | 2018 | 42 | 0.190 |
Why?
|
Models, Statistical | 6 | 2008 | 574 | 0.190 |
Why?
|
Adaptive Immunity | 2 | 2019 | 164 | 0.190 |
Why?
|
Staining and Labeling | 1 | 2021 | 165 | 0.190 |
Why?
|
Male | 24 | 2021 | 40956 | 0.190 |
Why?
|
Risk Factors | 10 | 2014 | 5416 | 0.180 |
Why?
|
Angiography | 7 | 1995 | 208 | 0.180 |
Why?
|
Parenchymal Tissue | 1 | 2019 | 6 | 0.170 |
Why?
|
Microscopy, Fluorescence, Multiphoton | 1 | 2019 | 14 | 0.170 |
Why?
|
Bayes Theorem | 7 | 2013 | 361 | 0.170 |
Why?
|
Mouth Neoplasms | 1 | 2021 | 194 | 0.170 |
Why?
|
Lung Diseases | 7 | 2000 | 263 | 0.170 |
Why?
|
Documentation | 2 | 2010 | 98 | 0.170 |
Why?
|
Television | 4 | 1986 | 29 | 0.170 |
Why?
|
Gadolinium DTPA | 5 | 2014 | 261 | 0.160 |
Why?
|
Pandemics | 2 | 2021 | 740 | 0.160 |
Why?
|
Workflow | 1 | 2018 | 77 | 0.160 |
Why?
|
Osteolysis | 2 | 2008 | 14 | 0.160 |
Why?
|
Densitometry | 3 | 2010 | 29 | 0.160 |
Why?
|
Computer Systems | 4 | 2000 | 79 | 0.150 |
Why?
|
Prospective Studies | 3 | 2021 | 4210 | 0.150 |
Why?
|
Glucocorticoids | 1 | 2020 | 352 | 0.150 |
Why?
|
Kidney Failure, Chronic | 1 | 2022 | 509 | 0.150 |
Why?
|
History, 21st Century | 1 | 2018 | 175 | 0.150 |
Why?
|
Models, Theoretical | 7 | 2009 | 482 | 0.150 |
Why?
|
Gastrointestinal Diseases | 1 | 1998 | 146 | 0.150 |
Why?
|
Likelihood Functions | 3 | 2013 | 251 | 0.140 |
Why?
|
Biomarkers, Tumor | 2 | 2016 | 1464 | 0.140 |
Why?
|
History, 20th Century | 1 | 2018 | 312 | 0.140 |
Why?
|
Genetic Predisposition to Disease | 6 | 2019 | 2270 | 0.140 |
Why?
|
Nephritis, Interstitial | 1 | 2016 | 47 | 0.140 |
Why?
|
Inflammation | 3 | 2022 | 920 | 0.140 |
Why?
|
Terminology as Topic | 1 | 2018 | 217 | 0.140 |
Why?
|
United States | 7 | 2022 | 6665 | 0.140 |
Why?
|
Teleradiology | 1 | 1996 | 4 | 0.140 |
Why?
|
Arthroplasty, Replacement, Hip | 2 | 2008 | 102 | 0.140 |
Why?
|
Time Factors | 8 | 2015 | 5209 | 0.140 |
Why?
|
Kidney | 3 | 2022 | 1241 | 0.140 |
Why?
|
Evaluation Studies as Topic | 11 | 2012 | 274 | 0.130 |
Why?
|
X-Ray Intensifying Screens | 5 | 1993 | 32 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 189 | 0.130 |
Why?
|
Dendritic Cells | 1 | 2019 | 425 | 0.130 |
Why?
|
Biophysical Phenomena | 12 | 2000 | 120 | 0.130 |
Why?
|
Prognosis | 4 | 2018 | 3674 | 0.130 |
Why?
|
Biophysics | 12 | 2000 | 152 | 0.130 |
Why?
|
Femur Neck | 5 | 2006 | 44 | 0.130 |
Why?
|
Disease-Free Survival | 1 | 2018 | 1204 | 0.130 |
Why?
|
Device Approval | 2 | 2012 | 13 | 0.130 |
Why?
|
Cardiomegaly | 2 | 2014 | 111 | 0.130 |
Why?
|
Young Adult | 6 | 2016 | 5974 | 0.130 |
Why?
|
Manganese | 1 | 2014 | 53 | 0.130 |
Why?
|
Fourier Analysis | 7 | 2014 | 125 | 0.130 |
Why?
|
Colonic Diseases | 1 | 2015 | 65 | 0.130 |
Why?
|
Information Storage and Retrieval | 4 | 2006 | 120 | 0.130 |
Why?
|
Primary Health Care | 1 | 1998 | 339 | 0.130 |
Why?
|
Probability | 3 | 2014 | 355 | 0.130 |
Why?
|
Atherosclerosis | 2 | 2007 | 243 | 0.130 |
Why?
|
Kinetics | 3 | 2013 | 1513 | 0.130 |
Why?
|
Vascular Access Devices | 1 | 2014 | 5 | 0.130 |
Why?
|
Lymphocytes | 1 | 2016 | 464 | 0.130 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 316 | 0.120 |
Why?
|
Fuzzy Logic | 4 | 2010 | 15 | 0.120 |
Why?
|
Coronavirus Infections | 1 | 2020 | 301 | 0.120 |
Why?
|
Datasets as Topic | 1 | 2014 | 71 | 0.120 |
Why?
|
Radiation Dosage | 5 | 2023 | 227 | 0.120 |
Why?
|
Thorax | 1 | 2014 | 75 | 0.120 |
Why?
|
Sutures | 1 | 2014 | 52 | 0.120 |
Why?
|
Ultrasonography | 4 | 2013 | 695 | 0.120 |
Why?
|
Biomechanical Phenomena | 3 | 2013 | 457 | 0.120 |
Why?
|
Apoptosis | 2 | 2019 | 1683 | 0.120 |
Why?
|
Holistic Health | 1 | 1993 | 8 | 0.120 |
Why?
|
Surveys and Questionnaires | 1 | 2021 | 2501 | 0.120 |
Why?
|
Adolescent | 6 | 2016 | 8979 | 0.120 |
Why?
|
Philosophy, Medical | 1 | 1993 | 17 | 0.120 |
Why?
|
Decision Making, Computer-Assisted | 1 | 1993 | 12 | 0.120 |
Why?
|
Expert Systems | 1 | 1993 | 18 | 0.120 |
Why?
|
Catheterization, Central Venous | 1 | 2014 | 116 | 0.120 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 1384 | 0.120 |
Why?
|
Heterozygote | 1 | 2014 | 365 | 0.120 |
Why?
|
Suture Techniques | 1 | 2014 | 135 | 0.120 |
Why?
|
Confidence Intervals | 3 | 2012 | 229 | 0.110 |
Why?
|
Gene Expression | 2 | 2016 | 1284 | 0.110 |
Why?
|
Statistics as Topic | 1 | 2014 | 238 | 0.110 |
Why?
|
Risk | 2 | 2013 | 674 | 0.110 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2014 | 132 | 0.110 |
Why?
|
Motion | 1 | 2013 | 85 | 0.110 |
Why?
|
Discriminant Analysis | 6 | 2013 | 66 | 0.110 |
Why?
|
Complementary Therapies | 1 | 1993 | 54 | 0.110 |
Why?
|
Bacterial Infections | 1 | 2014 | 182 | 0.110 |
Why?
|
Professional Competence | 1 | 2013 | 68 | 0.110 |
Why?
|
Glucuronosyltransferase | 1 | 2014 | 184 | 0.110 |
Why?
|
Nonlinear Dynamics | 2 | 2010 | 73 | 0.110 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2015 | 229 | 0.110 |
Why?
|
BRCA2 Protein | 5 | 2008 | 158 | 0.110 |
Why?
|
T-Lymphocytes | 1 | 2019 | 1195 | 0.110 |
Why?
|
Multimodal Imaging | 1 | 2013 | 110 | 0.110 |
Why?
|
Educational Status | 1 | 2013 | 188 | 0.110 |
Why?
|
Embolization, Therapeutic | 1 | 2015 | 238 | 0.110 |
Why?
|
Calcium | 2 | 2014 | 1156 | 0.110 |
Why?
|
Attitude | 1 | 2013 | 127 | 0.110 |
Why?
|
X-Ray Film | 8 | 1994 | 36 | 0.110 |
Why?
|
Prostatic Neoplasms | 2 | 2014 | 1720 | 0.100 |
Why?
|
Preventive Health Services | 1 | 2011 | 37 | 0.100 |
Why?
|
Linear Models | 2 | 2009 | 421 | 0.100 |
Why?
|
Equipment Failure Analysis | 3 | 2010 | 90 | 0.100 |
Why?
|
Genome, Human | 1 | 2015 | 756 | 0.100 |
Why?
|
Diffusion of Innovation | 1 | 2011 | 71 | 0.100 |
Why?
|
Research Design | 1 | 2014 | 594 | 0.090 |
Why?
|
Radiology Information Systems | 5 | 1999 | 76 | 0.090 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2013 | 294 | 0.090 |
Why?
|
Neoplasm Staging | 1 | 2015 | 1937 | 0.090 |
Why?
|
Animals | 5 | 2021 | 26581 | 0.090 |
Why?
|
Spinal Fractures | 2 | 2010 | 75 | 0.090 |
Why?
|
Quality of Life | 1 | 1998 | 1583 | 0.090 |
Why?
|
Diagnostic Errors | 5 | 2002 | 160 | 0.090 |
Why?
|
Anthropometry | 1 | 2010 | 74 | 0.090 |
Why?
|
Chicago | 2 | 2012 | 1379 | 0.090 |
Why?
|
Bone and Bones | 3 | 2000 | 265 | 0.090 |
Why?
|
Fractals | 6 | 2008 | 42 | 0.090 |
Why?
|
Equipment Design | 4 | 2015 | 406 | 0.090 |
Why?
|
Reference Standards | 2 | 2023 | 159 | 0.080 |
Why?
|
BRCA1 Protein | 3 | 2008 | 200 | 0.080 |
Why?
|
Fractures, Bone | 3 | 2006 | 131 | 0.080 |
Why?
|
Automation | 5 | 2014 | 106 | 0.080 |
Why?
|
Fibrocystic Breast Disease | 2 | 2005 | 12 | 0.080 |
Why?
|
Vascular Diseases | 1 | 1989 | 119 | 0.080 |
Why?
|
Filtration | 2 | 2006 | 25 | 0.080 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 1621 | 0.080 |
Why?
|
Microscopy, Fluorescence | 2 | 2021 | 425 | 0.080 |
Why?
|
Head and Neck Neoplasms | 1 | 2014 | 1052 | 0.070 |
Why?
|
Bias | 2 | 2014 | 127 | 0.070 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2006 | 34 | 0.070 |
Why?
|
Logistic Models | 1 | 2010 | 1185 | 0.070 |
Why?
|
Regression Analysis | 5 | 2010 | 596 | 0.070 |
Why?
|
Pregnancy | 2 | 2023 | 2893 | 0.070 |
Why?
|
Task Performance and Analysis | 1 | 2005 | 86 | 0.070 |
Why?
|
Age Factors | 4 | 2014 | 1849 | 0.060 |
Why?
|
Radionuclide Imaging | 4 | 2011 | 220 | 0.060 |
Why?
|
Computers | 3 | 2000 | 112 | 0.060 |
Why?
|
Copying Processes | 2 | 1994 | 6 | 0.060 |
Why?
|
Chi-Square Distribution | 3 | 2014 | 364 | 0.060 |
Why?
|
Databases as Topic | 5 | 2002 | 92 | 0.060 |
Why?
|
Biomedical Engineering | 1 | 2003 | 20 | 0.060 |
Why?
|
Mathematics | 6 | 1995 | 190 | 0.060 |
Why?
|
Genetic Association Studies | 2 | 2015 | 294 | 0.060 |
Why?
|
Genetic Carrier Screening | 1 | 2002 | 60 | 0.060 |
Why?
|
Neoplasm Grading | 2 | 2016 | 357 | 0.050 |
Why?
|
Monte Carlo Method | 1 | 2023 | 185 | 0.050 |
Why?
|
Quality Assurance, Health Care | 1 | 2004 | 220 | 0.050 |
Why?
|
Cluster Analysis | 3 | 2010 | 369 | 0.050 |
Why?
|
Abdomen | 1 | 2023 | 122 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2015 | 7988 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 2 | 2014 | 860 | 0.050 |
Why?
|
Mesocricetus | 1 | 2021 | 107 | 0.050 |
Why?
|
Incidence | 2 | 2012 | 1576 | 0.050 |
Why?
|
Radiologists | 1 | 2021 | 46 | 0.050 |
Why?
|
United States Food and Drug Administration | 2 | 2012 | 127 | 0.050 |
Why?
|
Colonic Polyps | 1 | 2001 | 126 | 0.050 |
Why?
|
Ribs | 2 | 1998 | 45 | 0.050 |
Why?
|
Germ-Line Mutation | 1 | 2002 | 329 | 0.050 |
Why?
|
Statistics, Nonparametric | 2 | 2011 | 307 | 0.040 |
Why?
|
Mass Screening | 5 | 2007 | 617 | 0.040 |
Why?
|
China | 1 | 2020 | 228 | 0.040 |
Why?
|
Heart Rate | 2 | 2014 | 492 | 0.040 |
Why?
|
Models, Structural | 3 | 1993 | 58 | 0.040 |
Why?
|
Switzerland | 1 | 1998 | 17 | 0.040 |
Why?
|
Lasers | 3 | 1993 | 106 | 0.040 |
Why?
|
Absenteeism | 1 | 1998 | 9 | 0.040 |
Why?
|
Visual Perception | 1 | 2022 | 319 | 0.040 |
Why?
|
Somatoform Disorders | 1 | 1998 | 29 | 0.040 |
Why?
|
Life Change Events | 1 | 1998 | 48 | 0.040 |
Why?
|
Diaphragm | 1 | 1998 | 50 | 0.040 |
Why?
|
Acceleration | 2 | 2007 | 20 | 0.040 |
Why?
|
Liver | 2 | 2013 | 1229 | 0.040 |
Why?
|
Receptors, Progesterone | 1 | 2018 | 167 | 0.040 |
Why?
|
Early Diagnosis | 1 | 2017 | 131 | 0.040 |
Why?
|
Cognition | 1 | 2022 | 570 | 0.040 |
Why?
|
Mice, Inbred NZB | 1 | 2016 | 13 | 0.040 |
Why?
|
Laser Capture Microdissection | 1 | 2016 | 20 | 0.040 |
Why?
|
Echo-Planar Imaging | 1 | 2017 | 52 | 0.040 |
Why?
|
Bcl-2-Like Protein 11 | 1 | 2016 | 22 | 0.040 |
Why?
|
Palatine Tonsil | 1 | 2016 | 30 | 0.040 |
Why?
|
Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2016 | 35 | 0.040 |
Why?
|
Information Dissemination | 1 | 2017 | 103 | 0.040 |
Why?
|
Cell Nucleus | 1 | 2019 | 579 | 0.040 |
Why?
|
Receptors, Estrogen | 1 | 2018 | 384 | 0.040 |
Why?
|
Betacoronavirus | 1 | 2020 | 258 | 0.040 |
Why?
|
Antigen-Antibody Complex | 1 | 2016 | 87 | 0.040 |
Why?
|
Bridged Bicyclo Compounds, Heterocyclic | 1 | 2016 | 76 | 0.040 |
Why?
|
Germinal Center | 1 | 2016 | 55 | 0.040 |
Why?
|
Kidney Glomerulus | 1 | 2016 | 123 | 0.030 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2004 | 201 | 0.030 |
Why?
|
Infant | 1 | 2022 | 3045 | 0.030 |
Why?
|
Microscopy, Confocal | 1 | 2016 | 268 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 1961 | 0.030 |
Why?
|
Mice, Transgenic | 1 | 2019 | 1540 | 0.030 |
Why?
|
Diastole | 1 | 2014 | 144 | 0.030 |
Why?
|
Sulfonamides | 1 | 2016 | 300 | 0.030 |
Why?
|
Catheter-Related Infections | 1 | 2014 | 23 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2016 | 927 | 0.030 |
Why?
|
Surgical Wound Dehiscence | 1 | 2014 | 37 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2014 | 43 | 0.030 |
Why?
|
Pulmonary Embolism | 1 | 1997 | 221 | 0.030 |
Why?
|
Models, Biological | 3 | 2006 | 1749 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 552 | 0.030 |
Why?
|
Organ Size | 1 | 2014 | 364 | 0.030 |
Why?
|
Colectomy | 1 | 2015 | 167 | 0.030 |
Why?
|
Mice | 2 | 2019 | 11352 | 0.030 |
Why?
|
Anthroposophy | 1 | 1993 | 1 | 0.030 |
Why?
|
Homeopathy | 1 | 1993 | 1 | 0.030 |
Why?
|
Chiropractic | 1 | 1993 | 2 | 0.030 |
Why?
|
Acupuncture Therapy | 1 | 1993 | 11 | 0.030 |
Why?
|
Plants, Medicinal | 1 | 1993 | 42 | 0.030 |
Why?
|
Interleukins | 1 | 2014 | 134 | 0.030 |
Why?
|
Body Weight | 1 | 2014 | 459 | 0.030 |
Why?
|
Multigene Family | 1 | 2014 | 202 | 0.030 |
Why?
|
Cell Communication | 1 | 2014 | 194 | 0.030 |
Why?
|
Acute Disease | 1 | 2015 | 826 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2008 | 3636 | 0.030 |
Why?
|
Mass Chest X-Ray | 1 | 1992 | 6 | 0.030 |
Why?
|
Risk Management | 1 | 2012 | 43 | 0.030 |
Why?
|
Tomography, Emission-Computed | 1 | 1992 | 103 | 0.030 |
Why?
|
Intensive Care Units | 1 | 1996 | 373 | 0.030 |
Why?
|
Lipids | 1 | 2014 | 269 | 0.030 |
Why?
|
Water | 1 | 2014 | 275 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2016 | 1753 | 0.030 |
Why?
|
Spine | 1 | 1993 | 102 | 0.030 |
Why?
|
Child | 1 | 2023 | 6926 | 0.030 |
Why?
|
Age Distribution | 1 | 2012 | 204 | 0.030 |
Why?
|
Recurrence | 1 | 2015 | 1139 | 0.030 |
Why?
|
Computer Graphics | 1 | 2012 | 100 | 0.030 |
Why?
|
Gene Frequency | 1 | 2014 | 677 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2014 | 999 | 0.030 |
Why?
|
Sex Factors | 1 | 2014 | 1054 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2015 | 1135 | 0.020 |
Why?
|
Thoracic Diseases | 1 | 1991 | 25 | 0.020 |
Why?
|
MicroRNAs | 1 | 2015 | 534 | 0.020 |
Why?
|
Spectrum Analysis | 2 | 1991 | 118 | 0.020 |
Why?
|
Comorbidity | 1 | 2014 | 943 | 0.020 |
Why?
|
Computational Biology | 1 | 2014 | 528 | 0.020 |
Why?
|
Conflict of Interest | 1 | 2011 | 67 | 0.020 |
Why?
|
Graft Rejection | 1 | 2016 | 1065 | 0.020 |
Why?
|
Lumbar Vertebrae | 2 | 2006 | 148 | 0.020 |
Why?
|
Alleles | 1 | 2014 | 1127 | 0.020 |
Why?
|
Europe | 1 | 2011 | 309 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2014 | 1924 | 0.020 |
Why?
|
Republic of Korea | 1 | 2009 | 31 | 0.020 |
Why?
|
Kidney Transplantation | 1 | 2016 | 849 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2014 | 760 | 0.020 |
Why?
|
Biometry | 2 | 1986 | 66 | 0.020 |
Why?
|
Prostatectomy | 1 | 2013 | 471 | 0.020 |
Why?
|
Case-Control Studies | 1 | 1994 | 1804 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2014 | 724 | 0.020 |
Why?
|
Xenon Radioisotopes | 2 | 2000 | 10 | 0.020 |
Why?
|
Ventilation-Perfusion Ratio | 2 | 2000 | 13 | 0.020 |
Why?
|
Genotype | 1 | 2014 | 1850 | 0.020 |
Why?
|
Urban Population | 1 | 2009 | 213 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 1989 | 213 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2014 | 3092 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2014 | 2232 | 0.020 |
Why?
|
In Vitro Techniques | 2 | 2000 | 989 | 0.020 |
Why?
|
Differential Threshold | 1 | 1987 | 12 | 0.020 |
Why?
|
Models, Neurological | 1 | 1990 | 405 | 0.020 |
Why?
|
Electricity | 1 | 1987 | 23 | 0.020 |
Why?
|
Heart Diseases | 1 | 1990 | 290 | 0.020 |
Why?
|
Metabolic Clearance Rate | 1 | 2006 | 121 | 0.020 |
Why?
|
Physical Phenomena | 1 | 1986 | 7 | 0.020 |
Why?
|
Hip Joint | 1 | 2006 | 55 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2014 | 2356 | 0.020 |
Why?
|
Analog-Digital Conversion | 1 | 1984 | 9 | 0.020 |
Why?
|
Myocardium | 1 | 2007 | 529 | 0.020 |
Why?
|
Weights and Measures | 1 | 1984 | 7 | 0.020 |
Why?
|
Prevalence | 1 | 2008 | 1239 | 0.020 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2004 | 33 | 0.020 |
Why?
|
Breast Cyst | 1 | 2004 | 4 | 0.020 |
Why?
|
Vascular Surgical Procedures | 1 | 2005 | 148 | 0.020 |
Why?
|
Research Support as Topic | 1 | 2003 | 80 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1990 | 1075 | 0.010 |
Why?
|
Tensile Strength | 1 | 1999 | 79 | 0.010 |
Why?
|
Joint Diseases | 1 | 1999 | 49 | 0.010 |
Why?
|
Genes, Tumor Suppressor | 1 | 2000 | 157 | 0.010 |
Why?
|
Fibroadenoma | 1 | 1999 | 9 | 0.010 |
Why?
|
Femur | 1 | 2000 | 116 | 0.010 |
Why?
|
Stress, Mechanical | 1 | 2000 | 248 | 0.010 |
Why?
|
Pleural Effusion | 1 | 1998 | 45 | 0.010 |
Why?
|
Decision Making | 1 | 2004 | 642 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2005 | 1034 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2000 | 532 | 0.010 |
Why?
|
Information Systems | 1 | 1995 | 29 | 0.010 |
Why?
|
Printing | 1 | 1994 | 4 | 0.010 |
Why?
|
Mediastinum | 1 | 1994 | 46 | 0.010 |
Why?
|
Radiography, Abdominal | 1 | 1993 | 71 | 0.010 |
Why?
|
Coronary Angiography | 1 | 1993 | 232 | 0.010 |
Why?
|
Pulmonary Fibrosis | 1 | 1993 | 123 | 0.010 |
Why?
|
Transcription Factors | 1 | 2000 | 1565 | 0.010 |
Why?
|
Databases, Bibliographic | 1 | 1991 | 17 | 0.010 |
Why?
|
Japan | 1 | 1992 | 307 | 0.010 |
Why?
|
Luminescent Measurements | 1 | 1991 | 57 | 0.010 |
Why?
|
Decision Trees | 1 | 1990 | 63 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 1993 | 451 | 0.010 |
Why?
|
Pneumothorax | 1 | 1991 | 52 | 0.010 |
Why?
|
Illinois | 1 | 1990 | 462 | 0.010 |
Why?
|
Models, Anatomic | 1 | 1988 | 91 | 0.000 |
Why?
|
Hand | 1 | 1988 | 130 | 0.000 |
Why?
|
Decision Theory | 1 | 1986 | 3 | 0.000 |
Why?
|